The Spanish Competition Authority authorizes the takeover of a medical equipment and supply manufacturer by a company that makes and sells medical devices related to urology and endocrinology (Coloplast / Atos)
Coloplast acquires control of Atos.*
On 21 December 2021, the CNMC authorised the takeover of Atos
Access to this article is restricted to subscribers
Already Subscribed? Sign-in